(19)
(11) EP 1 928 431 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
08.04.2009 Bulletin 2009/15

(45) Mention of the grant of the patent:
31.12.2008 Bulletin 2009/01

(21) Application number: 06779688.8

(22) Date of filing: 23.08.2006
(51) International Patent Classification (IPC): 
A61K 9/50(2006.01)
 A61K 31/403(2006.01)
(86) International application number:
PCT/HU2006/000068
(87) International publication number:
WO 2007/023325 (01.03.2007 Gazette 2007/09)

(54)

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITION CONTAINING CARVEDILOL

CARVEDILOL ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT KONTROLLIERTER FREISETZUNG

COMPOSITION PHARMACEUTIQUE A LIBERATION LENTE CONTENANT CARVEDILOL

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
Designated Extension States:
AL BA HR MK RS

(30) Priority: 26.08.2005 HU 0500803 P

(43) Date of publication of application:
11.06.2008 Bulletin 2008/24

(73) Proprietor: Egis Gyógyszergyár Nyilvánosan Múködö Részvénytársaság
1106 Budapest (HU)

(72) Inventors:
  • FEKETE, Pál
    H-1147 Budapest (HU)
  • BUDAVARI, Zoltán
    H-1124 Budapest (HU)
  • ZSIGMOND, Zsolt
    H-1173 Budapest (HU)
  • BOZSO, Agnes
    H-2060 Bicske (HU)
  • LEVENTISZNE HUSZAR, Magdolna
    H-1125 Budapest (HU)
  • PALFI, Zoltánné
    H-1172 Budapest (HU)
  • SZENTGROTI, Pálné
    H-1071 Budapest (HU)
  • DAVIDNE KARACS, Erika
    H-2220 Vecsés (HU)
  • TUROCZINE KUNCZE, Anikó
    H-1165 Budapest (HU)
  • ABRAHAM, Krisztina
    H-2711 Tápioszentmárton (HU)

(74) Representative: Beszédes, Stephan G. 
Münchner Strasse 80 A
D-85221 Dachau
D-85221 Dachau (DE)


(56) References cited: : 
WO-A-03/074032
WO-A2-02/065834
 WO-A-20/04056336
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).